Epigenetic changes cooperate with genetic alterations to play key roles in cancer initiation and progression. These changes involve DNA methylation, histone modification, histone modifying enzymes, and chromatin remodeling that regulate gene expression. PTMab® antibodies spanning important epigenetic markers, regulators, and histone modifications offers critical tools for cancer epigenetics, to enable studies in mechanism underlying cancer phenotypes and provide implications for cancer detection, prevention, and even treatment. Here are our products for key cancer epigenetic targets relevant to:
Would you like to see other products?
View all products
